NorthBayBusinessJournal -- SANTA ROSA – Human trials begin this week on a device that could change the way a chronic, universal disease is treated. A Santa Rosa medical device startup is targeting a huge global market for varicose veins, a painful but often untreated condition that affects 20 percent of the population.
